Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Web Exclusives |19 April 2016

Annals for Educators - 19 April 2016 Free

Darren B. Taichman, MD, PhD

Darren B. Taichman, MD, PhD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • Visit Annals Teaching Tools for more resources for educators from Annals and ACP.

    From the Editors of Annals of Internal Medicine and Education Guest Editor, Gretchen Diemer, MD, FACP, Associate Dean of Graduate Medical Education and Affiliations, Thomas Jefferson University.

×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • Clinical Practice Points
    • Clinical Guideline
    • Humanism and Professionalism
    • Role Models and Teachers
    • Teaching Opportunities From the American College of Physicians
    • MKSAP 17 Question
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link
  • CiteULike Link

Clinical Practice Points

Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing

Patients may share the results of direct-to-consumer personal genomic testing with their primary care provider. This study describes a group of consumers who shared their results with their primary care provider and whether they were satisfied or dissatisfied with the experience.
Use this study to:
  • Ask your learners if any of their patients have pursued direct-to-consumer genomic testing.

  • Look at the reports promised by one company. Do your learners feel prepared to review the results of such testing with their patients? If a patient provides a list of such results, what obligation do your learners feel to review and understand them? How long would it take to fully understand them? Is it different from any other test result that a patient may have had elsewhere?

  • Should your learners try to counsel a patient about the meaning of the presence of a gene variant? Do all such questions require evaluation by a geneticist? How will your learners decide? Invite a geneticist to join your conversation.

  • What do patients who have such testing anticipate? Look at the Web sites of some companies offering these services. Do your learners feel such testing is of value? Use the accompanying editorial to help frame your discussion.

Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment. A Randomized Trial

Studies have shown that a “treat-to-target” strategy results in improved clinical outcomes among patients with early active rheumatoid arthritis (RA), but long-term data on this approach are lacking. The authors present outcomes among patients treated with this approach for 10 years as part of a trial that examined 4 treat-to-target strategies for RA.
Use this study to:
  • Start a teaching session with a multiple-choice question. We've provided one below.

  • Review when to consider and how to diagnose RA. Use the information in DynaMed Plus: Rheumatoid Arthritis to help prepare to teach (a benefit of your ACP membership).

  • Teach at the bedside! Examine the joints of patients with and without RA with your team. Ask a radiologist to review with your team the radiologic changes found in patients with RA.

  • Review the results of this randomized trial. What targets are used in a treat-to-target strategy? Ask your learners what the goals of therapy for RA are. How are they monitored? What should they ask their patients about, and how often? Is any testing routinely required?

Clinical Guideline

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

This synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes focuses on key areas necessary for managing the disease, preventing complications, and improving outcomes.
Use this guideline to:
  • List the variables noted in Table 1, and ask your learners if they know the ranges used to diagnose pre-diabetes and diabetes. Ask your learners if they know how to order an oral glucose tolerance test.

  • How frequently should hemoglobin A1c be measured? What are the limitations of hemoglobin A1c testing?

  • Ask what advice your learners would provide to a patient with hypoglycemia unawareness. How should treatment be adjusted in such patients?

  • How should glycemic targets be selected? Use Appendix Figure 2 to visualize the interplay among important variables to consider (e.g., life expectancy, the presence of vascular complications)

  • How do your learners select antihyperglycemic therapy for type 2 diabetes? Review the information in Figure 1. How and when do they select second and third agents?

Humanism and Professionalism

Judging the Past: How History Should Inform Bioethics

Discussions of past scandals have become an obligatory part of bioethics courses in undergraduate, graduate, medical, and other health professional schools. This paper revisits several scandals that are typically discussed in bioethics education and training to generate a more historically informed assessment of immoral behavior. It concludes with a quote from historian Susan Reverby: “It is too simple for us to see [these physicians] merely as evil men doing bad things a long time ago that contemporary researchers would never do and that somehow written informed consent alone protects against.”
Use this paper to:
  • Review succinctly the experiments performed in Tuskegee and Willowbrook, the lobotomies performed on patients with mental illness, and the other events described by the authors. Ask what breach of ethics occurred in each.

  • The authors stress that it is essential to understand the context in which the physicians who participated in these events found themselves. Ask your learners why. Might such contextualization be used to justify what happened? Instead, might it help us understand why it happened when it did?

  • The authors state that by understanding the context, “… we are forced to question whether the ethos and rationales of that era could resurface.” What motivations present at the time of these unethical practices are still present today? How have things changed?

  • The authors argue that such an emphasis is too often missing when these events are presented as though they merely involved monsters from an alien past. Read the quote above from Susan Reverby. Do your learners believe that the evil of the past could not surface in our more modern, ethically “enlightened” era?

  • Ask if written informed consent protects against abuse? How might a patient be coerced into participation? Are participants truly “informed” when signing an informed consent agreement?

Role Models and Teachers

On Being a Doctor: A Few Good Words

“Do you have any questions?” I asked. My brain immediately began chanting, “Please don't, please don't, please don't.” I thought the chant was quiet enough that only I could hear it, but my patient seemed to read my mind.
In this essay, Dr. Moriates discusses the small changes he and other teaching attendings made in the questions they asked on rounds to help improve patients' experiences
Use this essay to:
  • Prompt your trainees to discuss their own responsibilities as role models. But first, use it to ask yourself what language you use on rounds (body and words), and how it might shape the experience of your patients and the future practice of your trainees.

Teaching Opportunities From the American College of Physicians

Clinical Skills Workshop Proposals Wanted for IM 2018

Interested in teaching procedural, physical examination, or communication skills?
The ACP is now accepting proposals for hands-on, interactive workshops that focus on the acquisition or improvement of procedural skills, physical examination skills, and communication skills for Internal Medicine 2018, which will be held in New Orleans, Louisiana, on April 19-21, 2018.
To submit a proposal, complete the Proposal for Internal Medicine 2018 application. The deadline for applications is May 23, 2016.

MKSAP 17 Question

A 42-year-old woman is evaluated for a 6-month history of pain and swelling of several small hand joints, an elbow, and an ankle. She gets modest relief with naproxen. She has no other medical problems and takes no additional medications.
On physical examination, vital signs are normal. There are tenderness to palpation and swelling of the second and third proximal interphalangeal joints bilaterally, second and fifth metacarpophalangeal joints bilaterally, left wrist, right elbow, and right ankle. The remainder of the physical examination is normal.
Laboratory studies are significant for a rheumatoid factor of 85 U/mL (85 kU/L) and positive anti–cyclic citrullinated peptide antibodies.
Radiographs of the hands and wrists show periarticular osteopenia at the metacarpophalangeal joints and a marginal erosion at the right second metacarpal head.
Which of the following is the most appropriate initial treatment?
A. Hydroxychloroquine
B. Methotrexate
C. Rituximab
D. Tofacitinib
Correct Answer
B. Methotrexate
Educational Objective
Treat rheumatoid arthritis with methotrexate.
Critique
Treatment with methotrexate is indicated for this patient with rheumatoid arthritis (RA). She has a polyarticular inflammatory arthritis involving the small joints of the hands as well as a wrist and an ankle, with radiographically demonstrated marginal erosions and periarticular osteopenia and positive anti–cyclic citrullinated peptide antibodies and rheumatoid factor, all of which support a diagnosis of RA. Methotrexate with or without the addition of another disease-modifying antirheumatic drug (DMARD) should be instituted immediately in patients with erosive disease documented at disease onset. Methotrexate is the gold standard therapy because it is usually better tolerated than other DMARDs and has good efficacy, long-term compliance rates, and relatively low cost.
Hydroxychloroquine is indicated to treat early, mild, and nonerosive disease. Hydroxychloroquine therapy alone has not been shown to retard radiographic progression of RA and therefore should be used only in patients whose disease has remained nonerosive for several years. This patient has erosive disease, and hydroxychloroquine as a single agent is not appropriate.
Rituximab, the anti-CD20 B-cell depleting monoclonal antibody, is FDA approved for the treatment of moderately to severely active RA in combination with methotrexate in patients who have had an inadequate response to tumor necrosis factor α inhibitor therapy. Rituximab may also be considered for patients with high disease activity and poor prognostic features despite sequential nonbiologic DMARDs or methotrexate in combination with other DMARDs. It is not appropriate initial treatment for RA in a patient who has not been given a trial of methotrexate.
Tofacitinib is also indicated for use in the management of RA but only in patients who have already not responded to methotrexate alone. This relatively recent addition to the treatment armamentarium for RA is the first oral agent to be introduced in decades but is indicated for use in patients who are intolerant to or have had an inadequate response to methotrexate.
Key Point
Methotrexate is the initial treatment of choice for patients with new-onset, rapidly progressive, or erosive rheumatoid arthritis.
Bibliography
Singh JA, Furst DE, Bharat A, et al. 2012 Update of the 2008 American College Of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 May;64(5):625-39.
Do you like reading Annals for Educators? Receive it direct to your inbox. Please e-mail annalseducators@acponline.org to sign up today.

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

Not Available
Citations
Citation

Taichman DB. Annals for Educators - 19 April 2016. Ann Intern Med. ;164:ED8. doi: 10.7326/AFED201604190

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2019

×
Permissions

Published: Ann Intern Med. 2016;164(8):ED8.

DOI: 10.7326/AFED201604190

©
2016 American College of Physicians
0 Citations

Related Articles

Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial
Annals of Internal Medicine; 164 (8): 523-531
Annals for Educators - 1 May 2018
Annals of Internal Medicine; 168 (9): ED9
Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure
Annals of Internal Medicine; 167 (2): JC8
Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis
Annals of Internal Medicine; 167 (1): 8-16
View MoreView Less

Journal Club

Patients with new-onset rheumatoid arthritis had increased risk for ischemic and nonischemic heart failure
Annals of Internal Medicine; 167 (2): JC8
Review: In rheumatoid arthritis, adding rituximab to methotrexate improves clinical outcomes
Annals of Internal Medicine; 162 (12): JC9
Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes
Annals of Internal Medicine; 163 (6): JC2
In patients with rheumatoid arthritis, bDMARD therapy was not associated with malignant neoplasms
Annals of Internal Medicine; 168 (4): JC23
View MoreView Less

Related Point of Care

Rheumatoid Arthritis
Annals of Internal Medicine; 153 (1): ITC1-1
Palliative Care
Annals of Internal Medicine; 168 (5): ITC33-ITC48
Clostridioides difficile Infection
Annals of Internal Medicine; 169 (7): ITC49-ITC64
Systemic Lupus Erythematosus
Annals of Internal Medicine; 159 (7): ITC4-1
View MoreView Less

Related Topics

Cardiology
Coronary Risk Factors
Diabetes
Endocrine and Metabolism
Ethics

Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Ethics.

PubMed Articles

Now for the hard ones: is there a limit on CRISPR genome editing in crops?
J Exp Bot 2019;70(3):734-737.
EnsembleCNV: an ensemble machine learning algorithm to identify and genotype copy number variation using SNP array data.
Nucleic Acids Res 2019.
View More

Results provided by: PubMed

CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×